Beria; Italo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Beria; Italo.The latest application filed is for "asymmetric process for the preparation of thieno-indoles derivatives".

Company Profile

3.44.34

Beria; Italo - Nerviano IT
BERIA; Italo - Nerviano MI
Beria; Italo - Milan IT
Beria; Italo - Nerviano-Milan IT
Beria; Italo - Milano IT
Beria; Italo - Villamarzana IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Asymmetric process for the preparation of thieno-indoles derivatives Grant 10,556,913 - Beria , et al. Feb	2020-02-11
Asymmetric Process For The Preparation Of Thieno-indoles Derivatives App 20190071451 - BERIA; Italo ; et al.	2019-03-07
Asymmetric process for the preparation of thieno-indoles derivatives Grant 10,174,048 - Beria , et al. J	2019-01-08
Thieno-indole moieties and methods of treating using the same Grant 10,071,074 - Beria , et al. September 11, 2	2018-09-11
Asymmetric Process For The Preparation Of Thieno-indoles Derivatives App 20180215768 - BERIA; Italo ; et al.	2018-08-02
Morpholinyl anthracycline derivatives Grant 9,828,405 - Beria , et al. November 28, 2	2017-11-28
Functionalized Morpholinyl Anthracycline Derivatives App 20170312290 - Beria; Italo ; et al.	2017-11-02
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Grant 9,695,240 - Beria , et al. July 4, 2	2017-07-04
Thieno-indole Moieties And Methods Of Treating Using The Same App 20170071907 - Beria; Italo ; et al.	2017-03-16
Functionalized thieno-indole derivatives for the treatment of cancer Grant 9,561,290 - Beria , et al. February 7, 2	2017-02-07
Functionalized 9-bromo-camptothecin derivatives Grant 9,556,192 - Beria , et al. January 31, 2	2017-01-31
Thieno-indole moieties and methods of treating using the same Grant 9,527,863 - Beria , et al. December 27, 2	2016-12-27
Isoxazolo-quinazolines as modulators of protein kinase activity Grant 9,333,205 - Caldarelli , et al. May 10, 2	2016-05-10
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors Grant 9,309,253 - Caldarelli , et al. April 12, 2	2016-04-12
New Morpholinyl Anthracycline Derivatives App 20160075730 - BERIA; Italo ; et al.	2016-03-17
Functionalized 9-bromo-camptothecin Derivatives App 20150291613 - BERIA; Italo ; et al.	2015-10-15
Tricyclic Pyrrolo Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20150141408 - Caldarelli; Marina ; et al.	2015-05-21
Functionalized Thieno-indole Derivatives For The Treatment Of Cancer App 20150080316 - Beria; Italo ; et al.	2015-03-19
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors Grant 8,975,267 - Caldarelli , et al. March 10, 2	2015-03-10
Anthracycline Derivative Conjugates, Process For Their Preparation And Their Use As Antitumor Compounds App 20150051380 - Beria; Italo ; et al.	2015-02-19
Alkylating Agents App 20150051154 - Beria; Italo ; et al.	2015-02-19
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent Grant 8,927,530 - Valsasina , et al. January 6, 2	2015-01-06
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Grant 8,900,589 - Beria , et al. December 2, 2	2014-12-02
PLK inhibitor salts Grant 8,648,078 - Zampieri , et al. February 11, 2	2014-02-11
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives Grant 8,642,580 - Geroni , et al. February 4, 2	2014-02-04
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors Grant 8,623,876 - Caruso , et al. January 7, 2	2014-01-07
Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors Grant 8,614,220 - Caruso , et al. December 24, 2	2013-12-24
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors Grant 8,598,172 - Caruso , et al. December 3, 2	2013-12-03
Tricyclic Pyrrolo Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20130296305 - Caldarelli; Marina ; et al.	2013-11-07
Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors Grant 8,461,193 - Bandiera , et al. June 11, 2	2013-06-11
Isoxazolo-quinazolines As Modulators Of Protein Kinase Activity App 20130143896 - Caldarelli; Marina ; et al.	2013-06-06
Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors Grant 8,426,417 - Caruso , et al. April 23, 2	2013-04-23
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Grant 8,389,697 - Beria , et al. March 5, 2	2013-03-05
Substituted Pyrrolo-pyrazole Derivatives As Kinase Inhibitors App 20120277248 - CARUSO; Michele ; et al.	2012-11-01
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors Grant 8,227,472 - Caruso , et al. July 24, 2	2012-07-24
Plk Inhibitor Salts App 20120157468 - Zampieri; Massimo ; et al.	2012-06-21
Anthracycline Derivative Conjugates, Process For Their Preparation And Their Use As Antitumor Compounds App 20120130059 - Beria; Italo ; et al.	2012-05-24
Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors App 20120122882 - Caruso; Michele ; et al.	2012-05-17
Therapeutic Combination Comprising A Plk1 Inhibitor And An Antineoplastic Agent App 20120114641 - Valsasina; Barbara ; et al.	2012-05-10
Substituted Pyrrolo-pyrazole Derivatives Active As Kinase Inhibitors App 20110288088 - BANDIERA; Tiziano ; et al.	2011-11-24
Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors Grant 7,968,583 - Bandiera , et al. June 28, 2	2011-06-28
Substituted Dihydropteridin-6-one Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20110053944 - Caruso; Michele ; et al.	2011-03-03
Substituted Pyrazolo-quinazoline Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20100216808 - Caruso; Michele ; et al.	2010-08-26
Anthracycline Derivative Conjugates, Process For Their Preparation And Their Use As Antitumor Compounds App 20100034837 - Beria; Italo ; et al.	2010-02-11
Substituted Pyrrolo-pyrazole Derivatives As Kinase Inhibitors App 20100010008 - Caruso; Michele ; et al.	2010-01-14
Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetabolite Grant 7,642,229 - Geroni , et al. January 5, 2	2010-01-05
Substituted Pyrrolo-pyrazole Derivatives Active As Kinase Inhibitors App 20090163503 - Bandiera; Tiziano ; et al.	2009-06-25
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors App 20070249651 - Geroni; Maria Cristina ; et al.	2007-10-25
Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione Grant 7,030,089 - Geroni , et al. April 18, 2	2006-04-18
Process for preparing distamycin derivatives Grant 6,951,951 - Beria , et al. October 4, 2	2005-10-04
Glutathiaone conjugates with distamycin derivatives having antitumoral activity Grant 6,838,547 - Beria , et al. January 4, 2	2005-01-04
Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents Grant 6,753,316 - Cozzi , et al. June 22, 2	2004-06-22
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites App 20040092453 - Geroni, Maria Cristina Rosa ; et al.	2004-05-13
Process for preparing distamycin derivatives App 20040082759 - Beria, Italo ; et al.	2004-04-29
Glutathiaone conjugates with distamycin derivatives having antitumoral activity App 20040038905 - Beria, Italo ; et al.	2004-02-26
Process for preparing distamycin derivatives App 20040029810 - Beria, Italo ; et al.	2004-02-12
Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione App 20030207794 - Geroni, Maria Cristina ; et al.	2003-11-06
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents App 20030180383 - Geroni, M. Cristina ; et al.	2003-09-25
Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase I and II inhibitors App 20030162722 - Geroni, Maria Cristina ; et al.	2003-08-28
Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents Grant 6,596,845 - Cozzi , et al. July 22, 2	2003-07-22
Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents App 20030023031 - Cozzi, Paolo ; et al.	2003-01-30
Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents Grant 6,458,768 - Cozzi , et al. October 1, 2	2002-10-01
Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents Grant 6,165,980 - Cozzi , et al. December 26, 2	2000-12-26
Distamycin A analogues as antitumour or antiviral agents Grant 5,753,629 - Beria , et al. May 19, 1	1998-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.